Ett medicinskt life science-innovationsbolag

Stockholm, Sverige




AUXESIS PHARMA HOLDING AB (publ) has now entered into an agreement with the issuance institute Avanza Sweden.
All shareholders will be registered with Euroclear via Avanza, and according to our joint plan before July 2023. 

Legal Entity Identifier (LEI) code is now registered for AUXESIS PHARMA HOLDING AB (publ).